A. Devico

发表

Immune-correlates analysis of an HIV-1 vaccine efficacy trial.

Guido Ferrari, Youyi Fong, Jaranit Kaewkungwal, 2012, The New England journal of medicine.

Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells

S. Arya, A. Garzino-Demo, R. Gallo, 1995, Science.

Human neutrophil α‐defensin 4 inhibits HIV‐1 infection in vitro

Jacek Lubkowski, J. Lubkowski, Wuyuan Lu, 2005 .

Identifying CCR5 coreceptor populations permissive for HIV-1 entry and productive infection: implications for in vivo studies

M. Reitz, O. Latinovic, Y. Tagaya, 2022, Journal of Translational Medicine.

Synergistic inhibition of R5 HIV-1 by maraviroc and CCR5 antibody HGS004 in primary cells: implications for treatment and prevention

A. Heredia, M. Reitz, N. Le, 2011, AIDS.

Rapamycin reduces CCR5 mRNA levels in macaques: potential applications in HIV-1 prevention and treatment

A. Heredia, N. Le, R. Redfield, 2007, AIDS.

Antigenic Properties of the HIV Envelope on Virions in Solution

J. Lakowicz, G. Lewis, K. Ray, 2013, Journal of Virology.

Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection

R. Redfield, M. Sajadi, R. Gallo, 2009, Proceedings of the National Academy of Sciences.

An immunoglobulin fusion protein based on the gp120-CD4 receptor complex potently inhibits human immunodeficiency virus type 1 in vitro.

Brenda K. Mcdermott, D. Israel, A. Devico, 2006, AIDS research and human retroviruses.

Expression and Characterization of a Single-Chain Polypeptide Analogue of the Human Immunodeficiency Virus Type 1 gp120-CD4 Receptor Complex

M. Reitz, R. Tuskan, G. Lewis, 2000, Journal of Virology.

Identification and Characterization of an Immunogenic Hybrid Epitope Formed by

G. Lewis, A. Devico, T. Fouts, 2011 .

Identification and Characterization of an Immunogenic Hybrid Epitope Formed by both HIV gp120 and Human CD4 Proteins

G. Lewis, A. Devico, Y. Guan, 2011, Journal of Virology.

Identification and Characterization of an Immunogenic Hybrid Epitope Formed by both HIV gp 120 and Human CD 4 Proteins

James E. Robinson, G. Lewis, A. Devico, 2011 .

Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates

B. Korber, D. Montefiori, O. Yang, 2015, Journal of Virology.

CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1

A. Heredia, N. Le, R. Redfield, 2007, AIDS.

An Alteration of Human Immunodeficiency Virus gp41 Leads to Reduced CCR5 Dependence and CD4 Independence

A. Heredia, M. Reitz, J. Foulke, 2008, Journal of Virology.

Signature Biochemical Properties of Broadly Cross-Reactive HIV-1 Neutralizing Antibodies in Human Plasma

R. Redfield, M. Sajadi, M. Seaman, 2012, Journal of Virology.

A synthetic peptide fragment derived from RANTES is a potent inhibitor of HIV-1 infectivity despite a surprising lack of CCR5 receptor affinity

A. Devico, Emabelle J Ramnarine, Sandra C. Vigil-Cruz, 2003, Letters in Peptide Science.

Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1.

T. Copeland, R. Gallo, P. Lusso, 1990, AIDS research and human retroviruses.

N‐terminal proteolytic processing by cathepsin G converts RANTES/CCL5 and related analogs into a truncated 4‐68 variant

Wuyuan Lu, O. Hartley, Jean K. Lim, 2006, Journal of leukocyte biology.

Multiple pathways of amino terminal processing produce two truncated variants of RANTES/CCL5

Wuyuan Lu, Jean K. Lim, A. Devico, 2005, Journal of leukocyte biology.

Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding

M. Sajadi, James E. Robinson, M. Pazgier, 2012, Proceedings of the National Academy of Sciences.

λ Light Chain Bias Associated With Enhanced Binding and Function of Anti-HIV Env Glycoprotein Antibodies.

R. Redfield, M. Sajadi, H. Robinson, 2016, The Journal of infectious diseases.

Crosslinked HIV-1 envelope–CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques

D. Montefiori, R. Pal, A. Devico, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston.

J. Groopman, K. Mayer, R. Gallo, 1985, Annals of internal medicine.

Preclinical Evaluation of Synthetic −2 RANTES as a Candidate Vaginal Microbicide To Target CCR5

Wuyuan Lu, R. Gallo, A. Devico, 2006, Antimicrobial Agents and Chemotherapy.

Rational Engraftment of Quaternary-Interactive Acidic Loops for Anti-HIV-1 Antibody Improvement

M. Sajadi, P. Kwong, Y. Kwon, 2021, Journal of Virology.

Antibody persistence and T-cell balance: Two key factors confronting HIV vaccine development

R. Gallo, G. Lewis, A. Devico, 2014, Proceedings of the National Academy of Sciences.

Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxin.

G. Lewis, A. Devico, K. Bagley, 2003, Vaccine.

Progress toward the development of a bacterial vaccine vector that induces high-titer long-lived broadly neutralizing antibodies against HIV-1.

G. Lewis, A. Devico, K. Bagley, 2003, FEMS immunology and medical microbiology.

Evaluation of -2 RANTES vaginal microbicide formulations in a nonhuman primate simian/human immunodeficiency virus (SHIV) challenge model.

M. Reitz, R. Gallo, R. Pal, 2007, AIDS research and human retroviruses.

Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases

R. Redfield, M. Sajadi, Wuyuan Lu, 2012, Proceedings of the National Academy of Sciences.

Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M.

S. Nakamura, T. Copeland, R. Gallo, 1992, Science.

Patterns of conserved gp120 epitope presentation on attached HIV-1 virions

J. Spouge, J. Foulke, Mileidy W. Gonzalez, 2017, Proceedings of the National Academy of Sciences.

Soluble complexes of regulated upon activation, normal T cells expressed and secreted (RANTES) and glycosaminoglycans suppress HIV-1 infection but do not induce Ca(2+) signaling.

G. Lewis, A. Devico, J. Burns, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Inhibition of HIV-1 Infection by the β-Chemokine MDC

A. Garzino-Demo, R. Gallo, R. Pal, 1997 .

HIV Infection and Pathogenesis: What About Chemokines?

A. Garzino-Demo, R. Gallo, A. Devico, 1999, Journal of Clinical Immunology.

HIV Coreceptors and Chemokines as Therapeutic Targets Against HIV/AIDS

R. Gallo, A. Devico, 2001 .

A New Monoclonal Antibody, mAb 4A12, Identifies a Role for the Glycosaminoglycan (GAG) Binding Domain of RANTES in the Antiviral Effect against HIV-1 and Intracellular Ca2+ Signaling

R. Gallo, G. Lewis, A. Devico, 1998, The Journal of experimental medicine.

A New Monoclonal Antibody, mAb 4A12, Identiﬁes a Role for the Glycosaminoglycan (GAG) Binding Domain of RANTES in the Antiviral Effect against HIV-1 and Intracellular Ca 2 (cid:49) Signaling

R. Gallo, G. Lewis, A. Devico, 1998 .

C-C chemokine RANTES and HIV long terminal repeat-driven gene expression.

S. Arya, A. Garzino-Demo, R. Gallo, 1997, AIDS research and human retroviruses.

Response: Role of β-Chemokines in Suppressing HIV Replication

A. Garzino-Demo, R. Gallo, P. Lusso, 1996, Science.

Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.

S. Broder, C. Perno, M. Sarngadharan, 1988, Molecular pharmacology.

Inhibition of HIV-1 infection by the beta-chemokine MDC.

M. Brown, A. Garzino-Demo, R. Gallo, 1997, Science.

Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection.

R. Redfield, D. Margolis, A. Garzino-Demo, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Production of the HIV-Suppressive Chemokines CCL3/MIP-1α and CCL22/MDC Is Associated with More Effective Antiretroviral Therapy in HIV-Infected Children

J. Lambert, A. Tanuri, Jean K. Lim, 2007, The Pediatric infectious disease journal.

Differential polarization of immune responses by co-administration of antigens with chemokines.

A. Garzino-Demo, R. Gallo, S. Lim, 2004, Vaccine.

Identification of Near-Pan-neutralizing Antibodies against HIV-1 by Deconvolution of Plasma Humoral Responses

G. Cavet, R. Redfield, M. Sajadi, 2018, Cell.

Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1

M. Pazgier, A. Finzi, G. Lewis, 2015, Viruses.

Inhibition of human immunodeficiency virus type 1 and vaccinia virus infection by a dominant negative factor of the interferon regulatory factor family expressed in monocytic cells (antiviral activity/interferoni-stimulated response element/transcription factor ICSBP/DNA-binding domain/monocyte)

I. Wang, K. Ozato, R. Mark, 2016 .

Epitope target structures of Fc-mediated effector function during HIV-1 acquisition

M. Sajadi, M. Pazgier, G. Lewis, 2014, Current opinion in HIV and AIDS.

Synthesis, conformation, and immunogenicity of monosaccharide-centered multivalent HIV-1 gp41 peptides containing the sequence of DP178.

Lai-Xi Wang, I. Baskakov, G. Lewis, 2004, Bioorganic & medicinal chemistry.

Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens

R. Gallo, R. Pal, G. Lewis, 2007, Proceedings of the National Academy of Sciences.

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.

S. Arya, A. Garzino-Demo, R. Gallo, 1995, Science.

Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure.

J. Skurnick, S. Vermund, D. Nixon, 2002, The Journal of infectious diseases.

Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene.

T. Copeland, R. Gallo, A. Devico, 1985, Science.

Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.

T. Copeland, R. Gallo, A. Devico, 1986, Science.

Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro.

M. Reitz, H. Mitsuya, S. Broder, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro.

R. Letsinger, R. Pal, M. Sarngadharan, 1991, Biochemistry.

Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy.

J. Lambert, A. Tanuri, S. Nogueira, 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Purification and partial characterization of equine infectious anemia virus reverse transcriptase.

R. Gallo, R. Montelaro, A. Devico, 1991, Virology.

Concurrent Exposure of Neutralizing and Non-neutralizing Epitopes on a Single HIV-1 Envelope Structure

M. Pazgier, G. Lewis, K. Ray, 2019, Front. Immunol..

Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays

M. Sajadi, A. Harris, G. Lewis, 2020, PloS one.

Reverse transcriptase--a general discussion.

M. Sarngadharan, A. Devico, 1992, Journal of enzyme inhibition.

The role of chemokines in human immunodeficiency virus infection

K. Conant, A. Garzino-Demo, R. Gallo, 2000, Immunological reviews.

Control of HIV-1 infection by soluble factors of the immune response

R. Gallo, A. Devico, Robert C. Gallo, 2004, Nature Reviews Microbiology.

Induction of Neutralizing Antibodies against Human Immunodeficiency Virus Type 1 Primary Isolates by Gag-Env Pseudovirion Immunization

D. Montefiori, P. Spearman, Xuemin Chen, 2005, Journal of Virology.

Higher macrophage inflammatory protein (MIP)-1α and MIP-1β levels from CD8+ T cells are associated with asymptomatic HIV-1 infection

W. Blattner, R. Redfield, D. Margolis, 2000 .

Chemokine Receptors and Chemokines in HIV Infection

A. Garzino-Demo, R. Gallo, A. Devico, 1998, Journal of Clinical Immunology.

The V3 domain of the HIV–1 gp120 envelope glycoprotein is critical for chemokine–mediated blockade of infection

A. Garzino-Demo, R. Gallo, P. Lusso, 1996, Nature Medicine.

Infection with HTLV-III/LAV and transfusion-associated acquired immunodeficiency syndrome. Serologic evidence of an association.

H. Jaffe, R. Gallo, J. Curran, 1985, JAMA.

Rapamycin Reduces CCR5 Density Levels on CD4 T Cells, and This Effect Results in Potentiation of Enfuvirtide (T-20) against R5 Strains of Human Immunodeficiency Virus Type 1 In Vitro

A. Heredia, N. Le, R. Redfield, 2007, Antimicrobial Agents and Chemotherapy.

Conserved Molecular Signatures in gp120 Are Associated with the Genetic Bottleneck during Simian Immunodeficiency Virus (SIV), SIV-Human Immunodeficiency Virus (SHIV), and HIV Type 1 (HIV-1) Transmission

J. Spouge, Mileidy W. Gonzalez, G. Lewis, 2015, Journal of Virology.

Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments.

W. Blattner, C. Wambebe, R. Gallo, 2002, Journal of human virology.

Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family

Jerome H. Kim, X. Chen, H. Liao, 2012, Journal of Virology.

Antigenic Properties of the Human Immunodeficiency Virus Envelope Glycoprotein Gp120 on Virions Bound to Target Cells

G. Lewis, K. Ray, A. Devico, 2015, PLoS pathogens.

Inhibition of human immunodeficiency virus type 1 and vaccinia virus infection by a dominant negative factor of the interferon regulatory factor family expressed in monocytic cells.

I. Wang, K. Ozato, R. Buller, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Structural Definition of an Antibody-Dependent Cellular Cytotoxicity Response Implicated in Reduced Risk for HIV-1 Infection

J. Foulke, M. Sajadi, P. Acharya, 2014, Journal of Virology.

Antigen-Induced Allosteric Changes in a Human IgG1 Fc Increase Low-Affinity Fcγ Receptor Binding.

P. Wintrode, M. Pazgier, W. Tolbert, 2020, Structure.

Paring Down HIV Env: Design and Crystal Structure of a Stabilized Inner Domain of HIV-1 gp120 Displaying a Major ADCC Target of the A32 Region

M. Pazgier, W. Tolbert, N. Gohain, 2016, Structure.

Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1

M. Sajadi, P. Acharya, P. Kwong, 2015, Journal of Virology.

Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection

D. Montefiori, R. Zagursky, C. Labranche, 2015, Proceedings of the National Academy of Sciences.

HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaques.

D. Montefiori, D. Venzon, S. Reed, 2014, Virology.

HIV-1 Infection Response Implicated in Reduced Risk for Antibody-Dependent Cellular Cytotoxicity Structural Definition of an

J. Foulke, M. Sajadi, P. Acharya, 2014 .

HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses

R. Gallo, G. Lewis, A. Devico, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Newcastle Disease Virus Expressing Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Induces Strong Mucosal and Serum Antibody Responses in Guinea Pigs

P. Collins, S. Samal, A. Devico, 2011, Journal of Virology.

Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status.

W. Blattner, J. Margolick, R. Moss, 1999, Proceedings of the National Academy of Sciences of the United States of America.

A synthetic peptide fragment derived from RANTES is a potent inhibitor of HIV-1 infectivity despite a surprising lack of CCR5 receptor affinity

A. Devico, Emabelle J Ramnarine, Sandra C. Vigil-Cruz, 2006, Letters in Peptide Science.

A Synthetic Peptide Fragment Derived from RANTES is a Potent Inhibitor of HIV-1 Infectivity Despite a Surprising Lack of CCR5 Receptor Affinity

A. Devico, Emabelle J Ramnarine, Sandra C. Vigil-Cruz, 2004, Letters in Peptide Science.

Broadly Neutralizing Antibodies against HIV: Back to Blood.

M. Sajadi, G. Lewis, A. Devico, 2019, Trends in molecular medicine.

CD4-induced epitopes in the HIV envelope glycoprotein, gp120.

A. Devico, 2007, Current HIV research.

Mechanism of enzyme inhibition mediated by anti-reverse transcriptase antibodies from HIV type 1-infected individuals.

M. Sarngadharan, A. Devico, F. Veronese, 1994, AIDS research and human retroviruses.

Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector.

M. Reitz, G. Lewis, A. Devico, 2001, Vaccine.

High prevalence of serum antibodies to equine infectious anemia virus reverse transcriptase.

S. L. Le Grice, C. Issel, R. Montelaro, 1993, AIDS research and human retroviruses.

Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response

J. Berzofsky, G. Trinchieri, D. Venzon, 2019, The Journal of clinical investigation.

Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1.

G. Lewis, A. Devico, T. Fouts, 2002, Vaccine.

Human Th17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV Infection

L. Marchionni, A. Garzino-Demo, Lingling Sun, 2016, Journal of Virology.

Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1s

Sarah V. Mudrak, G. Ferrari, M. A. Moody, 2022, Frontiers in Immunology.

Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell‐mediated cytotoxicity assay

Y. Hu, R. Koup, G. Ferrari, 2018, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Purification and partial characterization of human immunodeficiency virus type 2 reverse transcriptase.

T. Copeland, R. Gallo, A. Devico, 1989, AIDS research and human retroviruses.

Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the β-chemokine macrophage inflammatory protein-1β

R. Gallo, G. Lewis, A. Devico, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Survivors Remorse: antibody‐mediated protection against HIV‐1

M. Pazgier, G. Lewis, A. Devico, 2017, Immunological reviews.

Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial

D. Montefiori, R. Gottardo, G. Ferrari, 2021, Vaccine.

An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus Macaques

R. Gallo, R. Pal, G. Lewis, 2016, Clinical and Vaccine Immunology.

Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic Assays

M. Sajadi, G. Lewis, N. Constantine, 2020, medRxiv.

Stoichiometric Analyses of Soluble CD4 to Native-like HIV-1 Envelope by Single-Molecule Fluorescence Spectroscopy

J. Foulke, M. Pazgier, G. Lewis, 2019, Cell reports.

Replacement of ART with HIV Broadly Neutralizing Antibodies to Maximize the Effectiveness of Chemotherapy in HIV Patients with Lung Cancer.

E. Sausville, A. Heredia, N. Le, 2023, AIDS research and human retroviruses.

Antigenic Properties of the Human Immunodeficiency Virus Envelope during Cell-Cell Fusion

G. Lewis, A. Devico, C. Finnegan, 2001, Journal of Virology.

Role of β-Chemokines in Suppressing HIV Replication

J. Levy, A. Garzino-Demo, R. Gallo, 1996, Science.

Correlation Between Circulating HIV-1 RNA and Broad HIV-1 Neutralizing Antibody Activity

R. Redfield, M. Hossain, M. Seaman, 2011, Journal of Acquired Immune Deficiency Syndromes.

Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.

J. Lubkowski, Wuyuan Lu, R. Lehrer, 2005, FEBS Letters.

Beta-chemokines and protection from HIV type 1 disease.

A. Garzino-Demo, R. Gallo, A. Devico, 1998, AIDS research and human retroviruses.

Enhanced Immune Responses to HIV-1 Envelope Elicited by a Vaccine Regimen Consisting of Priming with Newcastle Disease Virus Expressing HIV gp160 and Boosting with gp120 and SOSIP gp140 Proteins

D. Montefiori, C. Labranche, S. Samal, 2015, Journal of Virology.

Conserved signatures indicate HIV-1 transmission is under strong selection and thus is not a “stochastic” process

J. Spouge, Mileidy W. Gonzalez, A. Devico, 2017, Retrovirology.

Covalently crosslinked complexes of human immunodeficiency virus type 1 (HIV-1) gp120 and CD4 receptor elicit a neutralizing immune response that includes antibodies selective for primary virus isolates.

R. Pal, M. Sarngadharan, A. Devico, 1996, Virology.

Interaction of C-terminal sequences of human immunodeficiency virus reverse transcriptase with template primer.

T. Copeland, R. Gallo, A. Devico, 1991, The Journal of biological chemistry.

Identifying CCR5 coreceptor populations permissive for HIV-1 entry and productive infection: implications for in vivo studies

M. Reitz, O. Latinovic, Y. Tagaya, 2022, Journal of translational medicine.

Modulating the durability of anti-HIV gp120 antibody responses after vaccination: a comment on Wilson & Karp (2015)

R. Gallo, G. Lewis, A. Devico, 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.

Antigenic Properties of the Human Immunodeficiency Virus Transmembrane Glycoprotein during Cell-Cell Fusion

G. Lewis, A. Devico, C. Finnegan, 2002, Journal of Virology.

‘Self-Protection’ of Individual CD4+ T Cells against R5 HIV-1 Infection by the Synthesis of Anti-Viral CCR5 Ligands

G. Lewis, A. Devico, Y. Guan, 2008, PloS one.

Monoclonal antibodies raised against covalently crosslinked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp 120.

R. Pal, P. Lusso, M. Sarngadharan, 1995, Virology.

Conformational perturbation of the envelope glycoprotein gp120 of human immunodeficiency virus type 1 by soluble CD4 and the lectin succinyl Con A.

R. Pal, M. Sarngadharan, A. Devico, 1993, Virology.

Analogues of N-terminal truncated synthetic peptide fragments derived from RANTES inhibit HIV-1 infectivity.

A. Devico, Emabelle J Ramnarine, Sandra C. Vigil-Cruz, 2006, Bioorganic & medicinal chemistry letters.

Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta -chemokine macrophage inflammatory protein-1beta.

R. Gallo, G. Lewis, A. Devico, 2001, Proceedings of the National Academy of Sciences of the United States of America.

High prevalence of serum antibodies to reverse transcriptase in HIV-1-infected individuals.

R. Gallo, A. Devico, M. Sarngadharan, 1988, AIDS research and human retroviruses.

Antigenic Properties of the HIV Envelope on Virions in Solution

J. Lakowicz, G. Lewis, K. Ray, 2013, Journal of Virology.

221 Humoral Immunity against Conserved Epitopes of HIV-1 Envelope Protein Archived in Memory B cells in Natural Viral Suppressors: Discordance with Plasma Antibodies

R. Redfield, R. Gallo, R. Pal, 2009 .

J. Spouge, Mileidy W. Gonzalez, G. Lewis, 2015, Journal of Virology.

Discordant Antigenic Properties of Soluble and Virion SARS-CoV-2 Spike Proteins

A. Devico, Mohammad M. Sajadi, Krishanu Ray, 2024, Viruses.